Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Majority of newborn babies with spinal muscular atrophy (SMA) treated with Evrysdi (risdiplam) are able to sit independently after 1 year of treatment – Roche

Written by | 10 Oct 2023

Roche presented positive results from the primary analysis of the ongoing RAINBOWFISH study assessing the efficacy and safety of Evrysdi (risdiplam) in babies with pre-symptomatic SMA (n=26), aged… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.